From: The role of the intra-abdominal view in complicated intra-abdominal infections
Risk factor | n (%) | SCIAS or 30-day mortality, n (%) | OR (95% CI) | P value | B |
---|---|---|---|---|---|
Perforated organ | |||||
Appendix | 109 (39) | 5 (5) | Reference | < 0.001 | |
Gallbladder | 11 (4) | 4 (36) | 11.89 (2.60–54.42) | 0.001 | 2.475 |
Colorectal | 101 (36) | 37 (37) | 12.03 (4.49–32.18) | < 0.001 | 2.487 |
Gastroduodenal | 32 (11) | 12 (38) | 12.48 (3.96–39.33) | < 0.001 | 2.524 |
Small bowel | 30 (11) | 13 (43) | 15.91 (5.03–50.33) | < 0.001 | 2.767 |
Non-appendiceal source* | 174 (62) | 66 (38) | 12.71 (4.93–32.81) | < 0.001 | 2.542 |
Extent of peritonitis by number of affected areas | |||||
1 | 30 (11) | 4 (13) | Reference | 0.001 | |
2 | 47 (17) | 7 (15) | 1.14 (0.30–4.28) | 0.849 | 0.129 |
3 | 29 (10) | 1 (3) | 0.23 (0.02–2.21) | 0.204 | − 1.460 |
4 | 32 (11) | 8 (25) | 2.17 (.58–8.13) | 0.252 | 0.773 |
5 | 32 (11) | 7 (22) | 1.82 (0.47–6.99) | 0.383 | 0.599 |
6 | 113 (40) | 44 (39) | 4.15 (1.35–12.69) | 0.013 | 1.422 |
Diffuse peritonitis (≥ 4 areas)* | 177 (63) | 59 (33) | 3.92 (1.99–7.71) | < 0.001 | 1.365 |
Bowel dilatation | |||||
No bowel dilatation | 164 (58) | 35 (21) | Reference | 0.097 | |
Small bowel only | 77 (27) | 19 (25) | 1.21 (0.64–2.29) | 0.563 | 0.188 |
Colon only* | 19 (7) | 8 (42) | 2.68 (1.00–7.17) | 0.050 | 0.986 |
Small bowel and colon | 23 (8) | 9 (39) | 2.37 (0.95–5.93) | 0.065 | 0.863 |
Type of exudate | |||||
Clear | 16 (6) | 3 (19) | Reference | 0.001 | |
Purulent | 160 (57) | 27 (17) | 0.88 (0.24–3.30) | 0.849 | − 0.128 |
Fecal | 85 (30) | 30 (35) | 2.36 (0.62–8.95) | 0.206 | 0.860 |
Bile | 22 (8) | 11 (52) | 4.33 (0.96–19.58) | 0.057 | 1.466 |
Fecal or bile* | 107 (38) | 41 (38) | 3.02 (1.74–5.26) | < 0.001 | 1.106 |
Extent of fibrin by number of affected areas | |||||
0 | 37 (13) | 15 (41) | Reference | < 0.001 | |
1 | 77 (27) | 12 (16) | 0.27 (0.11–0.67) | 0.004 | − 1.306 |
2 | 46 (16) | 7 (15) | 0.26 (0.09–0.74) | 0.120 | − 1.335 |
3 | 28 (10) | 3 (11) | 0.18 (0.05–0.69) | 0.130 | − 1.737 |
4 | 31 (11) | 6 (19) | 0.35 (0.12–1.06) | 0.640 | − 1.044 |
5 | 24 (9) | 10 (42) | 1.05 (0.37–2.98) | 0.930 | 0.047 |
6 | 39 (14) | 18 (46) | 1.26 (0.51–3.12) | 0.622 | 0.229 |
Amount of substantial fibrin by number of affected areas | |||||
0 | 140 (49) | 33 (24) | Reference | 0.016 | |
1 | 72 (25) | 12 (17) | 0.65 (0.31–1.35) | 0.246 | − 0.433 |
2 | 25 (9) | 6 (24) | 1.02 (0.38–2.78) | 0.963 | 0.024 |
3 | 19 (7) | 7 (37) | 1.89 (0.69–5.20) | 0.216 | 0.637 |
4 | 10 (4) | 2 (20) | 0.81 (0.16–4.01) | 0.797 | − 0.210 |
5 | 6 (2) | 4 (67) | 6.49 (1.14–37.01) | 0.035 | 1.869 |
6 | 11 (4) | 7 (64) | 5.67 (1.56–20.59) | 0.008 | 1.736 |
Substantial fibrin ≥ 5 or more areas* | 17 (6) | 11 (65) | 6.29 (2.2–17.73) | < 0.001 | 1.840 |
Extent of redness by number of affected areas | |||||
0 | 17 (6) | 8 (47) | Reference | < 0.001 | |
1 | 41 (14) | 6 (15) | 0.19 (0.05–0.70) | 0.012 | − 1.646 |
2 | 55 (19) | 7 (13) | 0.16 (0.05–0.57) | 0.004 | − 1.808 |
3 | 32 (11) | 3 (9) | 0.12 (0.03–0.53) | 0.006 | − 2.151 |
4 | 32 (11) | 7 (22) | 0.32 (0.09–1.12) | 0.074 | − 1.155 |
5 | 27 (10) | 7 (26) | 0.39 (0.11–1.42) | 0.155 | − 0.932 |
6 | 78 (28) | 33 (42) | 0.83 (0.29–2.37) | 0.720 | − 1.192 |
Amount of substantial redness by number of affected areas | |||||
0 | 125 (44) | 26 (21) | Reference | < 0.001 | |
1 | 73 (26) | 10 (14) | 0.60 (0.27–1.34) | 0.214 | − 0.504 |
2 | 34 (12) | 10 (29) | 1.59 (0.68–3.73) | 0.290 | 0.462 |
3 | 21 (7) | 5 (24) | 1.19 (0.40–3.55) | 0.755 | 0.174 |
4 | 9 (3) | 5 (56) | 4.76 (1.19–18.99) | 0.027 | 1.560 |
5 | 3 (1) | 2 (67) | 7.62 (0.66–87.29) | 0.103 | 2.030 |
6 | 18 (6) | 13 (72) | 9.90 (3.24–30.29) | < 0.001 | 2.293 |
Substantial redness ≥ 4 or more areas* | 30 (11) | 20 (67) | 7.92 (3.49–17.97) | < 0.001 | 2.070 |
Localization of cIAI non-parietal (only visceral) | 49 (17) | 11 (22) | 0.84 (0.40–1.75) | 0.639 | − 1.094 |